The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-Phenyl-6-(trifluoromethyl)-1H-pyrazolo[4,3-b]pyridin-1-yl)thiazole-4-carboxylic acid ID: ALA4128163
PubChem CID: 68259039
Max Phase: Preclinical
Molecular Formula: C17H9F3N4O2S
Molecular Weight: 390.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1csc(-n2nc(-c3ccccc3)c3ncc(C(F)(F)F)cc32)n1
Standard InChI: InChI=1S/C17H9F3N4O2S/c18-17(19,20)10-6-12-14(21-7-10)13(9-4-2-1-3-5-9)23-24(12)16-22-11(8-27-16)15(25)26/h1-8H,(H,25,26)
Standard InChI Key: UPPDSPSCYQRYKM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
35.4185 -3.8465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4173 -4.6661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1254 -5.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1236 -3.4377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8322 -3.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8325 -4.6616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6111 -4.9143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0921 -4.2518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6107 -3.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8613 -2.8140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6620 -2.6449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9143 -1.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3670 -1.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5642 -1.4341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3156 -2.2103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8679 -5.6935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3878 -6.3547 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.8684 -7.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6455 -6.7630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6452 -5.9458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.3490 -7.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3491 -7.9862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.0567 -6.7603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7093 -5.0741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0019 -4.6650 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.7086 -5.8913 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.9960 -5.4768 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
7 16 1 0
19 21 1 0
21 22 2 0
21 23 1 0
2 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.35Molecular Weight (Monoisotopic): 390.0398AlogP: 4.26#Rotatable Bonds: 3Polar Surface Area: 80.90Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.16CX Basic pKa: 0.01CX LogP: 4.54CX LogD: 1.09Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -1.59
References 1. Atobe M, Naganuma K, Kawanishi M, Hayashi T, Suzuki H, Nishida M, Arai H.. (2018) Discovery of a novel 2-(1H-pyrazolo[3,4-b]pyridin-1-yl)thiazole derivative as an EP1 receptor antagonist and in vivo studies in a bone fracture model., 28 (14): [PMID:29934246 ] [10.1016/j.bmcl.2018.06.022 ]